FDA Inspection 945679 — Jonathan W. Goldman, MD

Jonathan W. Goldman, MD — FEI 3011777413

The FDA completed an inspection of Jonathan W. Goldman, MD on October 15, 2015 in Santa Monica, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 15, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Santa Monica, CA (United States)

Additional Details

Clinical Investigator (CI)